Contribution: Industrial Research Assistance Program – Contributions to Firms
Allarta Life Science Inc.
$200,000.00
Development of degradable Cryoprotective Agents for Cell-based Therapies
FY 2024-25 · 2024-05-01
Summary
Non-cell permeating microgels are developed to promote cryopreservation with limited or no use of DMSO. This project aims to develop degradable microgels that are easy to separate from cell suspensions post-thawing. The microgels are being developed to work with a wide variety of cells and cell clusters.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Dundas|Dundas, Ontario, Canada
Recipient Type
For-profit organization
Business Number
735566085
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2025-03-31
Agreement Number
1020999
Agreement Start Date
2024-05-01
Agreement Title
Development of degradable Cryoprotective Agents for Cell-based Therapies
Agreement Title (French)
Développement d’agents cryoprotecteurs dégradables pour les thérapies cellulaires
Agreement Type
Contribution
Agreement Value
$200,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Non-cell permeating microgels are developed to promote cryopreservation with limited or no use of DMSO. This project aims to develop degradable microgels that are easy to separate from cell suspensions post-thawing. The microgels are being developed to work with a wide variety of cells and cell clusters.
Description (French)
Des microgels non perméables aux cellules sont développés pour favoriser la cryoconservation avec une utilisation limitée ou nulle de DMSO. Ce projet vise à développer des microgels dégradables faciles à séparer des suspensions cellulaires après décongélation. Les microgels sont développés pour fonctionner avec une grande variété de cellules et d’amas cellulaires.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Hamilton West--Ancaster--Dundas
Federal Riding (French)
Hamilton-Ouest--Ancaster--Dundas
Federal Riding Number
35038
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
735566085
Recipient City
Dundas|Dundas
Recipient Country
CA
Recipient Legal Name
Allarta Life Science Inc.
Recipient Operating Name
Allarta
Recipient Postal Code
L9H 2E7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2024-2025-Q2-1020999
